Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Alto Neuroscience announces new patent for depression treatment

January 15, 2026 Sales and Marketing Alto Neuroscience, Psychiatry, depression

Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …
News

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026 Sales and Marketing Arkin Capital, biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …
News

PSI announces new Osaka office as part of Japanese expansion

January 12, 2026 Sales and Marketing Osaka, PSI

PSI, a global contract research organisation (CRO), has announced the opening of a new office in Osaka as part of …
News

Andera Partners leads financing for asthma treatment company Spiro Medical

January 5, 2026 Sales and Marketing Andera Partners, Asthma & COPD, Spiro Medical

Andera Partners, a private equity firm, has announced its leadership of a $67m series A financing round in Spiro Medical, …
News

EIFO and FSG invest in Fida Biosystems to accelerate growth

December 15, 2025 Sales and Marketing EIFO, FSG, Fida Biosystems

The Export and Investment Fund of Denmark (EIFO) and Fåhraeus Startup and Growth Fund (FSG) have invested 5m euros in …
News

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025 Sales and Marketing Oncology, Osteoporosis, Samsung Bioepis

Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …
News

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025 Sales and Marketing Oncology, Osteoporosis, Sandoz

Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …
News

Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia

November 27, 2025 Product launch Gilead, HIV/AIDS

Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …
News

Cellbyte raises $2.75m to fund pharma drug launch platform

November 27, 2025 Product launch AI, Cellbyte, biotech

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …
News

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …
Feature
Thought Leadership

Turning a 10-Year Vision into a 10-Year Plan

October 27, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …
Feature

From sickness to prevention: the case for population health management

October 3, 2025 Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the third of the Gateway to Local Adoption series, Visions4Health caught up with James Scott, Digital and Informatics Specialist …
Feature

From Vaccine Innovation Pathway to growth powerhouse: how the UK is transforming clinical trials

October 2, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing 10 Year Health Plan, Life Sciences Sector Plan, NHS, National Institute for Health and Care Research, Pharmacy, UK Vaccine Innovation Pathway

Commercial clinical trials are a high-value growth driver for a country’s health and the economy and a key component of …
Feature
Thought Leadership

How pharma marketing needs to adapt as community pharmacies take centre stage

August 28, 2025 Business Services, Medical Communications, Sales and Marketing 10 Year Health Plan, Pharmacy, m3, pharmacy

The UK government’s 10-Year Health Plan is moving pharmacists to the frontline of primary care For decades, community pharmacies were …
Feature

The UK’s Life Sciences Sector Plan: a fresh launchpad or a continued labyrinth for the uptake of innovative medicines?

August 27, 2025 Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

As the UK healthcare system navigates a period of significant change, the path to successful market access is becoming increasingly …
Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026